首页
400-620-6333
凋亡
选项
-
-
Ozoralizumab (anti-TNF-alpha&HSA)简短描述: Purity≥90% (SDS-PAGE&SEC); Endotoxin Level≤1.0EU/mg; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated种属反应性: 人(Human)宿主种属: 人(Human) 偶联: UnconjugatedCAS号: 1167985-17-2
-
Brentuximab vedotin (anti-CD30)关联靶标: TNFRSF8简短描述: Purity>90% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Conjugated (MC-VC-PAB-MMAE)种属反应性: 人(Human) 亚型: Human IgG1宿主种属: 人(Human) 偶联: MC-VC-PAB-MMAECAS号: 914088-09-8SMILES: [Brentuximab vedotin]
-
Inezetamab (anti-CD40&MSLN)简短描述: Purity≥90% (SDS-PAGE&SEC-HPLC); Endotoxin Level<1.0 EU/mg; Human IgG1-EM-CGC; CHO; ELISA, Flow Cytometry, Functional assay, Animal Model; Unconjugated种属反应性: 人(Human) 亚型: Human IgG1-EM-CGC宿主种属: 人(Human) 偶联: UnconjugatedCAS号: 2568264-76-4
-
Linvoseltamab (anti-BCMA&CD3)简短描述: Purity≥95% (SDS-PAGE&SEC-HPLC); Endotoxin Level< 0.01EU/μg; Human IgG4SP; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated种属反应性: 人(Human) 亚型: Human IgG4SP宿主种属: 人(Human) 偶联: UnconjugatedCAS号: 2408319-25-3
-
Remtolumab (anti-IL-17A&TNF-alpha)简短描述: Purity≥90% (SDS-PAGE&SEC); Endotoxin Level≤1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated种属反应性: 人(Human) 亚型: Human IgG1宿主种属: 人(Human) 偶联: UnconjugatedCAS号: 1791410-27-9SMILES: [Remtolumab]
